Cellf-bio
Organization
People
Sources: reporter.nih.gov
Grants and prizes
National Institute of Diabetes and Digestive and Kidney Diseases
R44, BioSphincter to Treat Fecal Incontinence. Phase 1/2 Clinical Trial. SBIR Phase IIB, R44DK105593, US$1.4m, 2015–2024, Sep 1, 2021
Sources: reporter.nih.gov